Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Erlotinib can cause hair loss as a side effect.

Nilotinib can cause skin issues like red bumps and hair loss.

A woman's hair turned white after taking a cancer drug called dasatinib.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Nilotinib can cause generalized keratosis pilaris.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Gefitinib can cause hair and eyebrow darkening.

Certain drugs can change hair color, either lightening or darkening it.

Some drugs can cause permanent hair loss, though it's rare.

Gray hair can potentially be reversed, leading to new treatments.

EGFR inhibitors for lung cancer can cause severe skin issues.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Androgens increase growth factors in skin cells, which may lead to acne.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Axitinib treatment turned a man's grey hair back to black.

Nilotinib may cause gray hair to return to its original color.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The drug combination was safe and showed promise in treating advanced tumors.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.